Monday, January 18, 2021
Home Life Style Health & Fitness 'Sputnik V' COVID Vaccine Gets Approval for Clinical Trials in India

‘Sputnik V’ COVID Vaccine Gets Approval for Clinical Trials in India

Russian Vaccine Sputnik V Has Been Approved for Second and Third Phase Testing

The Drug Controller General of India (DCGI) has granted approval to Dr. Reddy’s, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, a COVID-19 vaccine made by Russia.

On September 16, the Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories Limited had agreed to cooperate on clinical trials and distribution of the Sputnik V COVID-19 vaccine in India.

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11.

Follow NewsGram on LinkedIn to know what’s happening around the world.

Co-chairman and Managing Director of Dr. Reddy’s Laboratories G.V. Prasad in a statement said “This is a significant development that allows us to commence the clinical trials in India and we are committed to bringing in a safe and efficacious vaccine to combat the pandemic.”

Sputnik V
The Drug Controller General of India (DCGI) has granted approval to Dr. Reddy’s, a global pharmaceutical company headquartered in India to Sputnik V made by Russia. Pixabay

“On regulatory approval in India, RDIF shall supply to Dr. Reddy’s 100 million doses of the vaccine. The Sputnik V vaccine, which is based on a well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic,” a statement from the Russian fund had earlier stated.

Also Read: Scientists Develop New Blood Test to Predict Which Covid-19 Patients at Severe Risk

The Russian Direct Investment Fund had also said that the deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

“The agreement between RDIF and Dr. Reddy’s reflects the growing awareness of countries and organizations to have a diversified anti-COVID vaccine portfolio to protect their populations,” RDIF added. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Book on Bihar’s Journey From Socialism To Saffronisation

Here's a book that aims to explore the story of conflict, confusion, and co-existence of the Socialist green and the BJPs saffron in Bihar. "JP...

Common Parasite In Uncooked Food May Cause Brain Cancer

If you eat undercooked meat then you may need to stop it, as researchers have found a link between Toxoplasma gondii (T. gondii) infection...

Raising Taxes on Tobacco Generates Revenue And Saves Lives

With the Covid-19 pandemic hitting the country's economy hard, preparation of the Union budget for the next fiscal is a big challenge for the...

Salaries To Housewives As Part of Electoral Campaign

Kamal Hasan's political party in Tamil Nadu promised salaries to housewives as part of its electoral campaign. And the idea was welcomed by Congress...

Tour Operators Urge Government To Announce About Restoration of Tourist Visas

Now that the government is close to initiating a vaccination plan for Covid-19, fresh hope is riding among inbound tour operators about the resumption...

Here’s Why Radha Rani is Worshipped Along With Lord Krishna

We have been listening to stories about the immortal love between Radha Rani and Lord Krishna since our childhood. They have been portrayed as...

Let Us Clear Your Data Security illusuion Here!

As millions shun WhatsApp and download new chat platforms in search for a secure experience, mind you that security is nothing but an illusion...

Tech Review (OnePlus Band): Good Looking Fitness Band With Decent Features

As the demand for wearable devices grows in India, OnePlus is leaving no stone unturned to use this opportunity in fulfulling consumers needs in...

Recent Comments